Atovaquon

Author:Prof. Dr. med. Peter Altmeyer

Last updated on: 29.10.2020

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).

Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Antiprotozoal agent.

Half-lifeThis section has been translated automatically.

> 50 h

IndicationThis section has been translated automatically.

Pneumocystis carinii pneumonia or toxoplasmosis in AIDS patients(replacement preparation especially for glucose-6-phosphate dehydrogenase deficiency).

Dosage and method of useThis section has been translated automatically.

3 times 750 mg/day p.o. during meals.

Undesirable effectsThis section has been translated automatically.

Nausea, diarrhoea, allergic reactions, headaches, vomiting, insomnia, increase in transaminases and amylases, anemia.

InteractionsThis section has been translated automatically.

See Table 1.

ContraindicationThis section has been translated automatically.

Pregnancy, nursing.

PreparationsThis section has been translated automatically.

Wellvone

TablesThis section has been translated automatically.

Essential interactions of Atovaquon

Aciclovir	Atovaquon plasma mirror ↓
Benzodiazepines	Atovaquon plasma mirror ↓
Cephalosporins	Atovaquon plasma mirror ↓
Fluconazole	Atovaquon plasma mirror ↓
Metoclopramide	Atovaquon plasma mirror ↓
Opiates	Atovaquon plasma mirror ↓
Paracetamol	Atovaquon plasma mirror ↓
Prednisolone	Atovaquon plasma mirror ↑
Rifampicin	Atovaquon plasma mirror ↓ by 50% ↓
Zidovudine (AZT)	Atovaquon ↑ Plasma level by 35%

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer